Synaffix BV
- Home
- Companies
- Synaffix BV
- Products
- GlycoConnect - Bispecific Antibody
GlycoConnect - Bispecific Antibody
FromSynaffix BV
Enabling immune cell engagers & other protein conjugates.
Most popular related searches
- Novel 2:1 format expected to deliver safety advantage
- Avoid co-expressing a genetic fusion of two separate antibodies / binding domains
- Directly convert any off-the-shelf antibody into a bispecific
Non-genetic Approach to Bispecifics
We use GlycoConnect™ to conjugate a separate antibody binding domain or cytokine (similar to an ADC payload), enabling bispecific immune cell engagers or checkpoint inhibitors from full-sized antibodies.